GE HealthCare Technologies Research and Development Expenses 2020-2025 | GEHC
GE HealthCare Technologies annual/quarterly research and development expenses history and growth rate from 2020 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
- GE HealthCare Technologies research and development expenses for the quarter ending March 31, 2025 were $344M, a 6.17% increase year-over-year.
- GE HealthCare Technologies research and development expenses for the twelve months ending March 31, 2025 were $1.331B, a 5.72% increase year-over-year.
- GE HealthCare Technologies annual research and development expenses for 2024 were $1.311B, a 8.8% increase from 2023.
- GE HealthCare Technologies annual research and development expenses for 2023 were $1.205B, a 17.45% increase from 2022.
- GE HealthCare Technologies annual research and development expenses for 2022 were $1.026B, a 25.74% increase from 2021.
| GE HealthCare Technologies Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $1,311 |
| 2023 | $1,205 |
| 2022 | $1,026 |
| 2021 | $816 |
| 2020 | $810 |
| 2019 | $833 |
| GE HealthCare Technologies Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $344 |
| 2024-12-31 | $344 |
| 2024-09-30 | $316 |
| 2024-06-30 | $327 |
| 2024-03-31 | $324 |
| 2023-12-31 | $315 |
| 2023-09-30 | $322 |
| 2023-06-30 | $298 |
| 2023-03-31 | $270 |
| 2022-12-31 | $271 |
| 2022-09-30 | $260 |
| 2022-06-30 | $257 |
| 2022-03-31 | $238 |
| 2021-12-31 | |
| 2021-09-30 | $0 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $30.985B | $19.672B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||